Berlin, Germany, June 3, 2016 / B3C newswire / -- BioGenes GmbH, a global leader in host cell protein (HCP) assay development, has entered into a collaboration with Eurofins BioPharma Product Testing Munich (Eurofins Munich), an internationally renowned  Contract Research Organization for (bio)pharmaceutical product-testing and Centre of Excellence for Bioassays, to serve as its preferred partner for HCP related impurity testing.

BioGenes will provide generic 360-HCP kits and specific HCP assay development services as well as related 2D electrophoresis (2D-DIGE) and concomitant antibody preparation. Eurofins Munich will provide complementary analytical services to BioGenes spanning the complete product development cycle from lead discovery to late stage clinical development.

Eurofins BioPharma Product Testing Munich GmbH, in cooperation with BSL Bioservice Scientific Laboratories Munich GmbH, supports its clients especially in the fields of bioassays, microbiology, in vitro toxicology, pharmacology, and biocompatibility. Immunoanalytical and bioanalytical studies are offered as support of non-clinical and clinical programs. Eurofins BioPharma Product Testing covers the whole range from standardized tests to special requirements and tailor-made studies.

With a strong dedication to quality and customer service since its foundation in 1992, BioGenes is the trusted and experienced immunoassay expert and a well-respected partner for leading pharmaceutical and biotech companies worldwide.

About BioGenes BioGenes GmbH specializes in highly sophisticated and customized antibody and immunoassay development and is an experienced and reliable partner for process development improvements in all areas of quality control, diagnostics and drug discovery. BioGenes is certified to meet the international requirements and regularities of quality assurance and animal welfare. The Company maintains long-term relationships with research institutes, universities and biotech and pharmaceutical companies, including eight of the ten largest pharmaceutical companies in the world. The company has been evaluated by a leading global accounting and auditing firm to be one of the leading companies in HCP assay development.

Contact

Dagmar Schwertner-Knoll Marketing/Sales Director BioGenes GmbH +49-30-65762380 dagmar.schwertner@biogenes.de

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.